Psoriatic Nail
9
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
Psorcast Mobile Study
A Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis
Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral
Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging
Clinical and Dermoscopic Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis Patients' Nails
Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines
Sonographic Analysis of Nails in Psoriatic Arthritis and Healthy Controls
Pulsed Dye Laser for the Psoriatic Nail